152 related articles for article (PubMed ID: 9715275)
21. [Genetics of renal tumors].
Oláh E; Jakab Z; Balogh E
Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
[TBL] [Abstract][Full Text] [Related]
22. Duplication of an approximately 1.5 Mb DNA segment at chromosome 5q22 indicates the locus of a new tumour gene in nonpapillary renal cell carcinomas.
Kenck C; Bugert P; Wilhelm M; Kovacs G
Oncogene; 1997 Mar; 14(9):1093-8. PubMed ID: 9070658
[TBL] [Abstract][Full Text] [Related]
23. Development of papillary renal cell tumours is associated with loss of Y-chromosome-specific DNA sequences.
Kovacs G; Tory K; Kovacs A
J Pathol; 1994 May; 173(1):39-44. PubMed ID: 7931836
[TBL] [Abstract][Full Text] [Related]
24. Novel intronic germline FLCN gene mutation in a patient with multiple ipsilateral renal neoplasms.
Gatalica Z; Lilleberg SL; Vranic S; Eyzaguirre E; Orihuela E; Velagaleti G
Hum Pathol; 2009 Dec; 40(12):1813-9. PubMed ID: 19733897
[TBL] [Abstract][Full Text] [Related]
25. Inactivation of BHD in sporadic renal tumors.
Khoo SK; Kahnoski K; Sugimura J; Petillo D; Chen J; Shockley K; Ludlow J; Knapp R; Giraud S; Richard S; Nordenskjöld M; Teh BT
Cancer Res; 2003 Aug; 63(15):4583-7. PubMed ID: 12907635
[TBL] [Abstract][Full Text] [Related]
26. Novel somatic mutations of the MET oncogene in human carcinoma metastases activating cell motility and invasion.
Lorenzato A; Olivero M; Patanè S; Rosso E; Oliaro A; Comoglio PM; Di Renzo MF
Cancer Res; 2002 Dec; 62(23):7025-30. PubMed ID: 12460923
[TBL] [Abstract][Full Text] [Related]
27. Metanephric adenoma lacks the gains of chromosomes 7 and 17 and loss of Y that are typical of papillary renal cell carcinoma and papillary adenoma.
Brunelli M; Eble JN; Zhang S; Martignoni G; Cheng L
Mod Pathol; 2003 Oct; 16(10):1060-3. PubMed ID: 14559991
[TBL] [Abstract][Full Text] [Related]
28. Analysis of somatic molecular changes, clinicopathological features, family history, and germline mutations in colorectal cancer families: evidence for efficient diagnosis of HNPCC and for the existence of distinct groups of non-HNPCC families.
Johnson V; Lipton LR; Cummings C; Eftekhar Sadat AT; Izatt L; Hodgson SV; Talbot IC; Thomas HJ; Silver AJ; Tomlinson IP
J Med Genet; 2005 Oct; 42(10):756-62. PubMed ID: 15788729
[TBL] [Abstract][Full Text] [Related]
29. Fluorescent microsatellite analysis reveals duplication of specific chromosomal regions in papillary renal cell tumors.
Palmedo G; Fischer J; Kovacs G
Lab Invest; 1997 Dec; 77(6):633-8. PubMed ID: 9426401
[TBL] [Abstract][Full Text] [Related]
30. Biological significance of c-met over expression in papillary renal cell carcinoma.
Sweeney P; El-Naggar AK; Lin SH; Pisters LL
J Urol; 2002 Jul; 168(1):51-5. PubMed ID: 12050491
[TBL] [Abstract][Full Text] [Related]
31. Renal tubulocystic carcinoma is closely related to papillary renal cell carcinoma: implications for pathologic classification.
Zhou M; Yang XJ; Lopez JI; Shah RB; Hes O; Shen SS; Li R; Yang Y; Lin F; Elson P; Sercia L; Magi-Galluzzi C; Tubbs R
Am J Surg Pathol; 2009 Dec; 33(12):1840-9. PubMed ID: 19898225
[TBL] [Abstract][Full Text] [Related]
32. Preferential germline mutation of the paternal allele in retinoblastoma.
Zhu XP; Dunn JM; Phillips RA; Goddard AD; Paton KE; Becker A; Gallie BL
Nature; 1989 Jul; 340(6231):312-3. PubMed ID: 2568588
[TBL] [Abstract][Full Text] [Related]
33. Novel germline c-MET mutation in a family with hereditary papillary renal carcinoma.
Wadt KA; Gerdes AM; Hansen TV; Toft BG; Friis-Hansen L; Andersen MK
Fam Cancer; 2012 Sep; 11(3):535-7. PubMed ID: 22717761
[TBL] [Abstract][Full Text] [Related]
34. Identification of a novel germline MET mutation in dogs.
Liao AT; McMahon M; London CA
Anim Genet; 2006 Jun; 37(3):248-52. PubMed ID: 16734685
[TBL] [Abstract][Full Text] [Related]
35. Sporadic bilateral papillary renal carcinoma exhibiting C-met mutation in the left kidney tumor.
Takaki Y; Furihata M; Yoshikawa C; Kishida T; Yao M; Shuin T
J Urol; 2000 Apr; 163(4):1241-2. PubMed ID: 10737508
[No Abstract] [Full Text] [Related]
36. Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.
Olivero M; Valente G; Bardelli A; Longati P; Ferrero N; Cracco C; Terrone C; Rocca-Rossetti S; Comoglio PM; Di Renzo MF
Int J Cancer; 1999 Aug; 82(5):640-3. PubMed ID: 10417759
[TBL] [Abstract][Full Text] [Related]
37. Duplications of DNA sequences between loci D20S478 and D20S206 at 20q11.2 and between loci D20S902 and D20S480 at 20q13.2 mark new tumor genes in papillary renal cell carcinoma.
Palmedo G; Fischer J; Kovacs G
Lab Invest; 1999 Mar; 79(3):311-6. PubMed ID: 10092067
[TBL] [Abstract][Full Text] [Related]
38. Identification of somatic mutations of the MEN1 gene in sporadic endocrine tumours.
Bergman L; Boothroyd C; Palmer J; Grimmond S; Walters M; Teh B; Shepherd J; Hartley L; Hayward N
Br J Cancer; 2000 Oct; 83(8):1003-8. PubMed ID: 10993646
[TBL] [Abstract][Full Text] [Related]
39. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit in patients with the Carney complex.
Kirschner LS; Carney JA; Pack SD; Taymans SE; Giatzakis C; Cho YS; Cho-Chung YS; Stratakis CA
Nat Genet; 2000 Sep; 26(1):89-92. PubMed ID: 10973256
[TBL] [Abstract][Full Text] [Related]
40. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer.
Tomlinson IP; Alam NA; Rowan AJ; Barclay E; Jaeger EE; Kelsell D; Leigh I; Gorman P; Lamlum H; Rahman S; Roylance RR; Olpin S; Bevan S; Barker K; Hearle N; Houlston RS; Kiuru M; Lehtonen R; Karhu A; Vilkki S; Laiho P; Eklund C; Vierimaa O; Aittomäki K; Hietala M; Sistonen P; Paetau A; Salovaara R; Herva R; Launonen V; Aaltonen LA;
Nat Genet; 2002 Apr; 30(4):406-10. PubMed ID: 11865300
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
